{
  "meta": {
    "title": "Normal_Development_Structure_And_Function",
    "url": "https://brainandscalpel.vercel.app/normal-development-structure-and-function-ea983e11.html",
    "scrapedAt": "2025-11-30T14:14:13.735Z"
  },
  "questions": [
    {
      "text": "A study was conducted on a medication to see how it affects joint damage in patients with rheumatoid arthritis. The medication works via inhibition of the enzyme dihydrofolate reductase. &#160;Five hundred patients were involved in the study; 250 patients were given a placebo, and 250 were given the medication tested. One year later, it was shown that the patients who took the study medication had significantly less joint damage than patients taking a placebo. Which of the following is a known contraindication for this study medication? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Congestive heart failure"
        },
        {
          "id": 2,
          "text": "Diabetes mellitus"
        },
        {
          "id": 3,
          "text": "Hypertension"
        },
        {
          "id": 4,
          "text": "Pregnancy"
        },
        {
          "id": 5,
          "text": "Smoking"
        }
      ],
      "correct_choice_id": 4,
      "solution": "The medication tested in this study is methotrexate, which is a folate antagonist that inhibits the enzyme dihydrofolate reductase. It is the first-line treatment for rheumatoid arthritis as it moderates joint damage. In addition, methotrexate is often used for other connective tissue disorders (e.g., psoriasis, systemic lupus erythematosus) and some cancers (e.g., leukemia/lymphoma and some solid tumors). Although the medication is generally well-tolerated and effective, it is contraindicated in some patients.<br><br>Methotrexate is contraindicated in pregnant women because of its severe teratogenic effects. Due to its folate antagonist properties, methotrexate can cause neural tube defects. In addition, methotrexate use is associated with many congenital disabilities, including cleft lip and palate, diaphragmatic hernia, and hypospadias. Finally, methotrexate can also lead to congenital heart defects (e.g., ventricular septal defects, atrial septal defects). Methotrexate should also be avoided in breastfeeding women as it is excreted in milk. Other contraindications include chronic liver disease (or patients with severe alcohol use disorder), severe chronic kidney disease, and pre-existing pancytopenia.<br>&#160; <div><img src=\"https://d16qt3wv6xm098.cloudfront.net/0lKeZOnjSna0sp29o8tX-7yJQ5qU5dRv/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Congestive heart failure:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Congestive heart failure is not a contraindication for methotrexate use. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Diabetes mellitus:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Diabetes mellitus is not a contraindication for methotrexate use. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Hypertension:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Hypertension is not a contraindication for methotrexate use. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Pregnancy:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Smoking:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: The medication used in the study is most likely methotrexate. Methotrexate is not contraindicated in patients who smoke or use tobacco. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 40-year-old man presents to the clinic due to joint pain for the last eight months. The pain is in multiple joints of both hands and is most severe in the morning. On physical examination, there is warmth and tenderness in both hands' bilateral wrists and the proximal interphalangeal joints. Radiography of the hands and wrists shows decreased joint space and periarticular osteopenia. The patient is prescribed a medication that inhibits the mitochondrial enzyme dihydroorotate dehydrogenase. Which of the following side effects would most likely result from this medication? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Cardiotoxicity"
        },
        {
          "id": 2,
          "text": "Hepatotoxicity"
        },
        {
          "id": 3,
          "text": "Mouth ulcers"
        },
        {
          "id": 4,
          "text": "Neurotoxicity"
        },
        {
          "id": 5,
          "text": "Syndrome of inappropriate antidiuretic hormone"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/eimnAfkwQCSy0ZgWpnhGDA24SEmPc5-L/_.png\"></div><br>This patient has most likely developed rheumatoid arthritis and is being prescribed leflunomide. Leflunomide is a disease-modifying anti-rheumatic drug (DMARD) frequently used in treating rheumatoid arthritis because it can slow down joint damage. It can also be used to treat psoriatic arthritis and some cancers.<br><br>The anti-inflammatory and immunomodulatory effects of leflunomide are due to its inhibition of the <strong>mitochondrial enzyme dihydroorotate dehydrogenase</strong>, which mediates the synthesis of the ribonucleotide uridine monophosphate, the rate-limiting step in de novo pyrimidine synthesis. Leflunomide, therefore, prevents the synthesis of pyrimidines, halting cells in the S-phase of the cell cycle. This results in the inhibition of proliferation and progression of activated lymphocytes, blocking an autoimmune reaction. <br><br>Leflunomide can cause diarrhea, rash, and hypersensitivity reactions. The most critical side effect of leflunomide is hepatotoxicity, so liver enzymes must be monitored. Finally, leflunomide can lead to pulmonary fibrosis. Thus, it is contraindicated in patients with chronic liver disease or interstitial lung disease. &#160;Finally, leflunomide is teratogenic and should be avoided in pregnancy.<br>&#160; <div><img src=\"https://d16qt3wv6xm098.cloudfront.net/xyLYYYVeSmG79i_oD5D092YnSnKIPXB3/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Cardiotoxicity:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: &#160;Cardiotoxicity can be seen with multiple medications, including doxorubicin and trastuzumab. It is not a known side-effect of leflunomide. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Hepatotoxicity:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Mouth ulcers:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Mouth ulcers can occur as a side effect of methotrexate, the first-line treatment of rheumatoid arthritis. It is not a side effect of leflunomide. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Neurotoxicity:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Neurotoxicity is not a known side effect of leflunomide. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Syndrome of inappropriate antidiuretic hormone:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: SIADH can occur as a side effect of several medications, commonly selective serotonin reuptake inhibitors. However, leflunomide is not associated with SIADH. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 40-year-old woman presents to the clinic due to joint pain and stiffness in both hands. The pain started eight months ago and has been progressively worsening. The pain is most severe in the morning, and the joint stiffness usually resolves about one hour after waking. Physical examination shows edema and erythema of the bilateral wrists and metacarpophalangeal joints. Radiography of both hands shows decreased joint space and periarticular osteopenia. Which of the following medications can be used to prevent the progression of joint damage? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Acetaminophen"
        },
        {
          "id": 2,
          "text": "Dexamethasone"
        },
        {
          "id": 3,
          "text": "Ibuprofen"
        },
        {
          "id": 4,
          "text": "Naproxen"
        },
        {
          "id": 5,
          "text": "Sulfasalazine"
        }
      ],
      "correct_choice_id": 5,
      "solution": "This patient has likely developed rheumatoid arthritis (RA), given the symptoms and radiographic findings. Disease-modifying anti-rheumatic drugs (DMARDs) should be started as soon as possible to slow down and moderate joint damage. NSAIDs and steroids can treat pain and stiffness in RA, but they do not slow the progression of joint damage. Sulfasalazine is a DMARD used in the treatment of rheumatoid arthritis. It is also used for ankylosing spondylitis, inflammatory bowel disease, and polyarticular juvenile idiopathic arthritis.<br><br>Sulfasalazine is a prodrug made of 5-aminosalicylate linked to sulfapyridine. The colonic bacteria activate this product in the gut, separating the two products. Mechanisms include inhibiting the expression of NF-KB and cytokines, stimulating adenosine production, and inhibiting B-cell antibody production.<br><br>Sulfasalazine lacks teratogenic effects but has many other side effects. These include malaise, nausea, rash (urticarial or maculopapular lesions), and oligospermia. More severe side effects include leukopenia, thrombocytopenia, hemolytic anemia, and elevated liver enzymes.<br>&#160; <div><img src=\"https://d16qt3wv6xm098.cloudfront.net/z3cg4H1UQrGYFSnG7Ebimty7Q3WD0iHB/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Acetaminophen:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Acetaminophen is an analgesic that relieves pain in rheumatoid arthritis, usually less so than NSAIDs. Acetaminophen does not have anti-inflammatory properties and would not prevent joint damage. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Dexamethasone:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Steroids can be used in patients with rheumatoid arthritis to decrease pain and relieve the stiffness of the involved joints. However, like NSAIDs, steroids DO NOT slow the progression of joint damage in rheumatoid arthritis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Ibuprofen:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Ibuprofen is an NSAID (non-steroidal anti-inflammatory drug) that can help with pain and stiffness in rheumatoid arthritis. NSAIDs do not slow down the joint damage, however. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Naproxen:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: &#160;Naproxen is another NSAID that can help with pain and stiffness in rheumatoid arthritis. NSAIDs do not slow down the joint damage, however. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Sulfasalazine:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 79-year-old woman presents to the primary care clinic to establish care. Over the past few months, she has had pain in the left knee that is worse when walking up and down stairs. She also has occasional pain in the right hip from prolonged walking and has pain and stiffness in both hands with a few bony growths noted. Both hands are stiff in the mornings, lasting 5 minutes. The pain in all joints is worse at the end of the day after hours of gardening. Past medical history is significant for dyslipidemia and hypertension, well-controlled with atorvastatin and losartan, respectively. Vital signs are unremarkable. On physical examination, the distal interphalangeal joints of two fingers have bony hypertrophy with limited range of motion but no erythema or swelling. The left knee has minimal effusion without erythema or warmth. There is medial joint line tenderness, &#160;limited range of motion, and crepitus with movement. There is a reduction in passive range of motion of the right hip. Serum complete blood count is within normal limits. Serum uric acid level is 8.4 mg/dL. What is the most likely diagnosis? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Osteoarthritis"
        },
        {
          "id": 2,
          "text": "Gout"
        },
        {
          "id": 3,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 4,
          "text": "Ankylosing spondylitis"
        },
        {
          "id": 5,
          "text": "Psoriatic arthritis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This 79-year-old woman presents with pain in both hands, the left knee, and the right hip. The pain is associated with less than 5 minutes of morning stiffness and worsens with use during the day. The left knee has evidence of a noninflammatory effusion with crepitus, joint line tenderness, and limited range of motion. The interphalangeal joints of the hands have evidence of bony hypertrophy. This patient&#8217;s age, history, and clinical exam are consistent with <strong>osteoarthritis</strong>.<br><br>Joint pain is a very common reason for patients to seek medical care, and it can be caused by a wide variety of local or systemic pathologies. To narrow down the differential diagnosis, it is helpful to classify the type of joint involvement. Joint pain can be <strong>traumatic&#160;</strong>or <strong>nontraumatic</strong>; and <strong>acute</strong>, <strong>subacute</strong>, or <strong>chronic</strong>. It can involve one joint (monoarticular), a few joints (oligoarticular), or multiple joints (polyarticular). It can affect mostly the skeleton (axial) or the extremities (peripheral). And finally, joint pain and swelling may be <strong>inflammatory&#160;</strong>(e.g. septic arthritis, rheumatoid arthritis) or <strong>non-inflammatory</strong> (<strong>e.g. osteoarthritis</strong>). The history and physical examination will provide clues to the diagnosis. Imaging, arthrocentesis (cell count, differential, gram stain, culture), and blood work may be needed to make the diagnosis.<br><br>Patients with osteoarthritis typically have joint pain that is <strong>worse with activity</strong>, as well as morning stiffness lasting <strong>less than 30 minutes</strong>. They typically experience limitations in functioning. Physical exam may show bony enlargement in the hands at the interphalangeal joints and the base of the thumb. The knees may exhibit bony enlargement, joint line tenderness, limited range of motion, and instability. Effusions may be present, but arthrocentesis will reveal synovial fluid that is non-inflammatory or only mildly inflammatory. Osteoarthritis typically affects the knees, hips, interphalangeal joints of the hands, the first CMC joints, first MTP joints, and facet joints of the lower cervical and lower lumbar spine. Diagnosis is made clinically, and radiographs can be used to help make the diagnosis. Characteristic findings on the x-ray include characteristic features of OA like marginal osteophytes, localized joint space narrowing, subchondral sclerosis, and cysts.<br>&#160; <div><img src=\"https://d16qt3wv6xm098.cloudfront.net/AEtRj3RpSSaqXF0W7tV5cOeNQLmJuLjj/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Osteoarthritis:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Gout:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Patients with gout typically present with acute flares involving one or occasionally a few joints that are painful, swollen, warm, and erythematous. This patient has a mildly elevated uric acid level, but this alone is not diagnostic of gout. This patient&#8217;s presentation is more characteristic of osteoarthritis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Rheumatoid arthritis:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: In rheumatoid arthritis (RA), patients typically have symmetric arthritis of the small joints of the hands and feet that is associated with over 30 minutes of morning stiffness, with the pain and stiffness improving with activity. Physical examination will reveal multiple small joints of the hands and feet with signs of inflammation, such as swelling, warmth, and erythema. This patient's presentation is more characteristic of osteoarthritis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Ankylosing spondylitis:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Patients with ankylosing spondyloarthritis typically present with chronic back pain before the age of 45. Patients are often young men with a family history of inflammatory back arthritis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Psoriatic arthritis:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Psoriatic arthritis typically presents in patients with skin psoriasis. Patients can have inflammatory arthritis of the peripheral joints, axial joints, or both. Patients may also have dactylitis (ie sausage digits), and nail changes. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "<span>A 60-year-old woman presents to the office because of a painful toe on her right foot. The patient reports the pain began suddenly, waking her up in the middle of the night. Past medical history is significant for hypertension, for which the patient takes hydrochlorothiazide. Physical examination shows a swollen and erythematous metatarsophalangeal (MTP) joint of the big toe. Joint aspiration and crystal analysis shows thin, tapered, needle-shaped intracellular crystals that are strongly negatively birefrin</span><span>gent. Laboratory results are shown below. Which of the following is&#160;</span><span>most likely responsible</span><span>&#160;for this patient&#8217;s presentation?</span>&#160;<br><br><table><tbody><tr><td>&#160;<span><strong>Laboratory value</strong></span>&#160; &#160;&#160;</td><td>&#160;<strong><span>Result</span>&#160; &#160; </strong></td></tr><tr><td>&#160;<span>Sodium&#160;</span>&#160; &#160;&#160;</td><td>&#160;<span>135&#160;</span><span>mEq</span><span>/L</span>&#160; &#160;&#160;</td></tr><tr><td>&#160;<span>Potassium&#160;</span>&#160; &#160;&#160;</td><td>&#160;<span>3.2&#160;</span><span>mEq</span><span>/L</span>&#160; &#160;&#160;</td></tr><tr><td>&#160;<span>Chloride</span>&#160; &#160;&#160;</td><td>&#160;<span>&#160;95&#160;</span><span>mEq</span><span>/L</span>&#160; &#160;&#160;</td></tr><tr><td>&#160;<span>Creatinine&#160;</span>&#160; &#160;&#160;</td><td>&#160;<span>1.0 mg/dL</span>&#160; &#160;&#160;</td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br>",
      "choices": [
        {
          "id": 1,
          "text": "Amlodipine&#160;"
        },
        {
          "id": 2,
          "text": "Hydrochlorothiazide&#160;"
        },
        {
          "id": 3,
          "text": "Spironolactone&#160;"
        },
        {
          "id": 4,
          "text": "Smoking&#160;"
        },
        {
          "id": 5,
          "text": "Allopurinol&#160;"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/V3HgK748Qbyoxc3xeFojoNGRTVW12cGf/_.png\"></div><br>The clinical picture and joint aspirate are consistent with gout, which results from tissue deposition of monosodium urate crystals due to supersaturation. Clinically, gout presents with arthritis (gouty arthritis) or tophi (chronic tophaceous gout) and the most common area of the body to be affected is the first toe. <strong>Thiazide diuretics</strong> are secreted by the same secretory system that secretes uric acid into the proximal tubule. Here they <strong>compete with the secretion of uric acid</strong>, therefore increasing uric acid levels in the blood and increasing risk of a <strong>gout attack</strong>.<br><br>Other adverse effects associated with thiazide diuretics include <strong>hypercalcemia, hyperglycemia, hyponatremia, and hyperlipidemia</strong>. Chronic therapy is often associated with potassium wasting since an increased sodium load is presented to the collecting tubules; the cortical collecting tubules compensate by reabsorbing sodium and excreting potassium.<br><br>Thiazide diuretics can also induce <strong>hypokalemic metabolic alkalosis</strong>. It happens because an increased concentration of sodium ions in the collecting duct makes the collecting duct secrete more potassium and hydrogen ions from the blood and into the urine. People with allergic reactions to sulfonamide medications may develop an allergic reaction to thiazides and thiazide-like diuretics. <br>&#160; <div><img src=\"https://d16qt3wv6xm098.cloudfront.net/qwDGkpAkStyObvUY2baM9K0uRxW41Eh4/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Amlodipine&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>:&#160;Calcium channel blockers can lower uric acid levels and are likely to reduce the risk of a gout attack.&#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Hydrochlorothiazide&#160;:</strong><br><span style='opacity:0.9'><strong>Correct</strong>:&#160;See Main Explanation.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Spironolactone&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: &#160;Spironolactone is a potassium-sparing diuretic and is likely to cause hyperkalemia (as opposed to this patient&#8217;s hypokalemia). Its other side effects include gynecomastia and antiandrogenic effects. It would not precipitate a gout attack.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Smoking&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>:&#160;Smoking is associated with decreased risk of gout due to decreased production of uric acid.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Allopurinol&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>:&#160;Allopurinol, a xanthine oxidase inhibitor, is prescribed as a prophylactic treatment for gout. It would not precipitate a new onset of gout.&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 63-year-old man presents to the emergency department from an acute rehabilitation center for evaluation of right knee pain and swelling for the past 48 hours. The patient underwent right knee arthroplasty approximately 1 week ago. The patient has been unable to ambulate secondary to pain. Past medical history includes hypertension and obesity. Temperature is 38&#176;C (102.2&#176;F), blood pressure is 98/71 mmHg, pulse is 109/min, respiratory rate is 20/min, and oxygen saturation is 99% on room air. On physical examination, there is a palpable effusion, warmth, marked swelling of the right knee when compared to the left, and severe pain with range of motion. The patient is unable to bear weight without significant pain. Radiographs of the right knee demonstrate periosteal reaction associated with the right knee prosthesis. Which of the following is the best next step in management? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Orthopedic surgical consultation for diagnosis and treatment"
        },
        {
          "id": 2,
          "text": "Administration of intra-articular kenalog"
        },
        {
          "id": 3,
          "text": "Discharge with outpatient orthopedic follow up"
        },
        {
          "id": 4,
          "text": "CT without contrast of right knee"
        },
        {
          "id": 5,
          "text": "Arthrocentesis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient who has recently received a prosthetic knee presents for evaluation of unilateral knee pain and swelling one week after surgery. &#160;The patient's overall clinical presentation and his imaging findings are concerning for <strong>septic arthritis</strong>. <strong>Orthopedic surgery</strong> should be consulted to determine whether or not to perform an arthrocentesis or to go directly to surgery for <strong>diagnosis and treatment with drainage or debridement</strong>.<br><br>The evaluation of patients with suspected septic arthritis is dependent on whether or not the patient has a native or a prosthetic joint that is affected. Patients with prosthetic joints should have x-ray imaging to evaluate for periosteal reactions, changes in prosthetic positioning, as well as abnormal lucencies that may suggest an underlying infectious process. <strong>Orthopedic surgeons</strong> will decide whether or not to proceed with arthrocentesis and synovial fluid analysis or to <strong>go directly to surgery where drainage/debridement</strong> can be performed along with fluid collection for analysis and cultures. Patients with concerning findings for septic arthritis should receive empiric antibiotics. Orthopedic surgery consultation should also be obtained for patients with native joint infections as they may require drainage and debridement and ongoing monitoring for response to therapy and tailored antibiotics. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Orthopedic surgical consultation for diagnosis and treatment:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Administration of intra-articular kenalog:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Administration of intraarticular kenalog is often indicated for the treatment of osteoarthritic pain. This patient has clinical examination and imaging findings that indicate septic arthritis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Discharge with outpatient orthopedic follow up:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This patient has clinical examination findings and imaging findings that indicate septic arthritis. He requires inpatient admission for urgent surgical consultation for diagnosis and treatment. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ CT without contrast of right knee:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: CT without contrast of the right knee is not part of the evaluation or treatment of patients with septic arthritis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Arthrocentesis:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Orthopedic surgical consultation should be obtained first for patients with suspected prosthetic joint infections. They will determine whether or not to perform an arthrocentesis or to go directly to surgery for diagnosis and treatment with drainage or debridement. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 62-year-old woman presents for evaluation of bilateral hand pain for 6 months. She describes the pain as a dull and achy pain that feels worse with activity and in the evenings. She works as an administrative assistant and types throughout the day. She rates the pain a 4-6 on a 10 point scale. She notes that she has some stiffness in the morning, but it resolves within 10 minutes. Her medical history is significant for diabetes mellitus, type 2 and hypercholesterolemia. Temperature is 36.8&#176;C (98.2&#176;F), pulse is 80/minute, respiratory rate is 16/minute, blood pressure is 128/72 mmHg, and BMI is 24 kg/m<sup>2</sup>. Physical examination is significant for mild tenderness to palpation and bony enlargement of the DIP and PIP joints of both hands without swelling. There is no erythema or warmth. The patient does not have rashes on skin examination. Which of the following is the most likely diagnosis? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Osteoarthritis"
        },
        {
          "id": 2,
          "text": "Rheumatoid Arthritis"
        },
        {
          "id": 3,
          "text": "Systemic Lupus Erythematosus"
        },
        {
          "id": 4,
          "text": "Gout"
        },
        {
          "id": 5,
          "text": "Psoriatic Arthritis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient presents with bilateral joint pain in the hands that <strong>worsens with activity and improves with rest</strong>. She also has morning stiffness that <strong>resolves within 10 minutes</strong>. The DIP and PIP joints are mostly involved and there is no significant boggy swelling or effusions in the joints. These findings are consistent with <strong>osteoarthritis (OA)</strong>. In contrast, inflammatory arthritis, which is seen in SLE, RA, gout, and psoriatic arthritis typically presents with joint stiffness that lasts longer than 30 minutes in the morning and improves with movement of the joints. Boggy swelling and effusions can indicate synovitis in inflammatory arthritis. While bony enlargement without boggy swelling and effusions is more often seen in osteoarthritis.<br><br>Risk factors for OA include genetics, biological female sex, past injury to involved joints, age, and obesity. Osteoarthritis can affect any joint, but most commonly affects the knees, hips, hands, feet, and spine. It typically presents in older patients from repetitive use of the joints leading to mechanical wear and tear of joints and hypertrophic changes. Hand osteoarthritis typically presents with bilateral joint pain and bony enlargements that affect the <strong>distal interphalangeal (DIP) joints (Heberden nodes), proximal interphalangeal (PIP) joints (Bouchard nodes)</strong>, and thumb bases. In contrast, RA of the hands affects the bilateral PIP, metacarpophalangeal, and wrist joints. <br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/s5t2B6FQS2WN-XkFY_HDz0KNR9SAwUJ0/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Osteoarthritis:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Rheumatoid Arthritis:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Rheumatoid arthritis typically presents with prolonged morning stiffness (&gt;30 minutes) and is more likely to affect the MCP joints and wrists. Joint examination will typically show joint swelling and bogginess indicative of synovitis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Systemic Lupus Erythematosus:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Patients with lupus may also present with joint pain affecting multiple joints. However, the arthritis that occurs with lupus tends to be migratory, the joints may also be swollen indicating synovitis. Patients also typically present with other symptoms to support a diagnosis of lupus such as fatigue, fever, hair loss, and myalgias. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Gout:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Patients with gout usually present with acute episodes affecting one or more joints that become inflamed, warm, swollen, erythematous, and tender to palpation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Psoriatic Arthritis:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Patients with psoriatic arthritis may present with joint pain affecting the entire digit associated with significant swelling. This patient has no rashes consistent with psoriatic arthritis and the rash typically precedes joint involvement. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 46-year-old man comes to the emergency department for evaluation of acute onset severe right foot pain associated with swelling and redness. The patient does not report any history of recent trauma. The patient has not experienced similar symptoms before. Past medical history is significant for hypertension and hyperlipidemia. Current medications include hydrochlorothiazide and atorvastatin. Family history is noncontributory. Temperature is 37.8&#176;C (100&#176;F), pulse is 90/min, respirations are 18/min and blood pressure is 125/75 mmHg. Physical examination shows redness, and warmth over the right great toe. A sample of synovial fluid shows needle-shaped negatively birefringent crystals under polarized light microscopy. Which of the following is the best next step in the management of this patient? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Administer allopurinol"
        },
        {
          "id": 2,
          "text": "Administer aspirin"
        },
        {
          "id": 3,
          "text": "Recommend an increase in organ-rich foods"
        },
        {
          "id": 4,
          "text": "Admit the patient for debridement"
        },
        {
          "id": 5,
          "text": "Administer oral naproxen"
        }
      ],
      "correct_choice_id": 5,
      "solution": "This patient presents with acute toe pain and associated erythema and swelling. These findings, in conjunction with needle-shaped negatively birefringent crystals under polarized light microscopy, is consistent with an acute gout flare secondary to monosodium urate deposition in the joint space. &#160; <br><br>The preferred first-line agent for acute gout flares is <strong>non-selective cyclooxygenase (COX) inhibitors</strong> such as <strong>naproxen, ibuprofen or ketorolac,</strong> which<strong>&#160;reversibly inhibit both COX-1 and COX-2;</strong> thereby, decreasing prostaglandin and thromboxane synthesis. &#160; &#160;<br><br>Non-selective COX inhibitors &#160;may be used for managing post-operative pain, dysmenorrhea, headache, and <strong>patent ductus arteriosus</strong> in premature infants (<strong>indomethacin</strong>). These medications can be taken perorally, but ketorolac, ibuprofen, and indomethacin are the only NSAIDs that are also available in parenteral form. Nonselective COX inhibitors reduce polyp formation in patients with primary familial adenomatous polyposis. &#160; <br><br>Common adverse effects include <strong>gastritis</strong>, gastric/duodenal ulcers or bleeding. &#160;There is a risk of kidney injury with the use of any NSAIDs, especially in patients with preexisting renal disease. Chronic abuse of NSAIDs can lead to <strong>analgesic nephropathy</strong>, which can manifest as chronic nephritis or renal papillary necrosis. &#160;<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/M8sRUNsZTgqvKsXf7KNsBryqSeSJyE9p/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Administer allopurinol:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Allopurinol is a xanthine oxidase inhibitor that is indicated in patients with recurrent gout attacks. It is not effective for acute gout flares.</span></div><div style='margin-bottom: 12px;'><strong>❌ Administer aspirin:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Aspirin should be avoided in patients with a history of gout as it competes with uric acid for excretion. It plays no role in the treatment of an acute gout attack.</span></div><div style='margin-bottom: 12px;'><strong>❌ Recommend an increase in organ-rich foods:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Organ-rich foods, such as liver, often result in an increased production of uric acid. Increasing its consumption can precipitate an acute gout attack.</span></div><div style='margin-bottom: 12px;'><strong>❌ Admit the patient for debridement:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>This patient&#8217;s presentation is consistent with an acute gout attack which can be managed by administration of an anti-inflammatory agent. Debridement is not required in these patients. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Administer oral naproxen:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 40-year-old man comes to the emergency department because of severe left ankle pain that awoke him from sleep. The pain is associated with swelling and redness. The patient has no history of recent trauma. Past medical history is significant for a recent renal transplantation, secondary to end-stage renal disease. Current medications include cyclosporine and low-dose prednisone. Family history is noncontributory. Temperature is 37.8&#176;C (100.0&#176;F), pulse is 90/min, respirations are 18/min, and blood pressure is 125/75 mmHg. Physical examination shows redness, warmth and swelling of the left ankle. A sample of synovial fluid shows needle-shaped negatively birefringent crystals under polarized light microscopy. After resolution of this acute episode, the patient is started on probenecid to prevent future episodes. Which of the following best describes the mechanism of action of this drug? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Reducing the conversion of purine metabolites to uric acid and xanthine"
        },
        {
          "id": 2,
          "text": "Converting uric acid into more soluble metabolites"
        },
        {
          "id": 3,
          "text": "Selective inhibition of microtubule assembly"
        },
        {
          "id": 4,
          "text": "Inhibition of renal reabsorption of uric acid"
        },
        {
          "id": 5,
          "text": "Selective, reversible inhibition of COX-2"
        }
      ],
      "correct_choice_id": 4,
      "solution": "The patient has acute monoarticular arthritis of the left ankle and microscopy reveals the presence of negatively birefringent needle-shaped crystals. Moreover, the patient is taking cyclosporine, which impairs renal excretion of uric acid. These findings are consistent with an acute gout flare. After the resolution of the current episode, the patient should be started on a<strong>&#160;uricosuric agent</strong> such as <strong>probenecid&#160;</strong>or <strong>sulfinpyrazone</strong>. &#160; <br><br>Uricosuric agents work by <strong>inhibiting renal tubular reabsorption of uric acid;</strong> thereby, increasing its excretion and reducing the risk of future gout attacks. These medications are typically reserved for patients who under excrete uric acid relative to their plasma levels. &#160; &#160; <br><br>However, uricosuric agents can inhibit the secretion of a large number of other weak acids (e.g., penicillin, cephalosporin, aspirin). As a result, combinations of these drugs should be avoided. Other side effects of uricosuric agent therapy are quite limited and include <strong>gastrointestinal irritation&#160;</strong>and <strong>hypersensitivity reactions.&#160;</strong>&#160;<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/Rr6sCS3CSQmU7BuLYpyUNm_eSGGeGh4h/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Reducing the conversion of purine metabolites to uric acid and xanthine:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Allopurinol and its active metabolite oxypurinol irreversibly inhibit xanthine oxidase and lowers production of uric acid and xanthine. In contrast, probenecid works by preventing uric acid reabsorption in the proximal convoluted tubule. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Converting uric acid into more soluble metabolites:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Urate oxidase facilitates the conversion of uric acid to a more soluble form, allantoin. Rasburicase is a recombinant version of urate oxidase. &#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Selective inhibition of microtubule assembly:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Colchicine binds to tubulin to inhibit microtubule formation. It can be used in the acute treatment of gout, but not for prophylaxis. &#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Inhibition of renal reabsorption of uric acid:</strong><br><span style='opacity:0.9'><strong>Correct: </strong>See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Selective, reversible inhibition of COX-2:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that helps decrease inflammation. It is not indicated for gout prophylaxis. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 49-year-old man presents to the clinic with a 6-month history of joint pain. The pain is localized to his fingers and toes, and he has no history of trauma to the areas. The pain is worse in the morning and is associated with swelling. He says he is able to perform his job on the computer, but he is limited to approximately an hour each morning. He has a 7-year history of psoriasis. Temperature is 37&#176;C (98.7&#176;F), pulse is 70/min, and blood pressure is 117/75 mmHg. Physical examination shows swelling of 5 distal and proximal joints of the fingers and 3 distal and proximal joints of the toes with tenderness to palpation without deformities. Nail findings are seen, as shown in the image below. Skin exam is significant for multiple erythematous and scaly plaques on both elbows and the buttocks. Laboratory studies reveal C-reactive protein (CRP) of 6 mg/L and erythrocyte sedimentation rate (ESR) (22 mm/hr). Radiographic findings show joint space narrowing in 3 distal interphalangeal joints of the fingers without evidence of pencil-in-cup deformities. Which of the following is the most appropriate initial treatment?<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/9UA26YeASc_xcuJO38pT_oadQaecFf0g/_.jpg\"></div><br>Image taken from Wikimedia",
      "choices": [
        {
          "id": 1,
          "text": "Methotrexate"
        },
        {
          "id": 2,
          "text": "Topical vitamin D analog"
        },
        {
          "id": 3,
          "text": "Topical calcineurin inhibitor"
        },
        {
          "id": 4,
          "text": "Secukinumab"
        },
        {
          "id": 5,
          "text": "Etanercept"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient with a history of skin psoriasis presents with <strong>pain, swelling, and tenderness</strong> of <strong>multiple distal joints&#160;</strong>of the hands and feet, <strong>nail changes (onycholysis) psoriatic arthritis (PsA),</strong> and elevated inflammatory markers. Given this patient&#8217;s history, clinical, and radiographic findings, he likely has <strong>moderate PsA,&#160;</strong>and he should be started on treatment with a first-line<strong>&#160;oral disease-modifying antirheumatic drug (DMARD)</strong> such as <strong>methotrexate&#160;</strong>(along with folic acid supplementation). &#160; <br><br>Treatment for PsA is targeted towards disease severity (<strong>mild, moderate,</strong> or <strong>severe</strong>). This patient with active psoriasis, multiple joint involvements (&gt;5), nail changes, mild limitations in functioning, and radiographic changes has <strong>moderate PsA</strong>, and he should be started on treatment with a disease-modifying antirheumatic drug (DMARD). &#160; &#160;<br><br>The first line DMARD typically used in PsA is methotrexate (MTX). MTX works by inhibiting dihydrofolate reductase, an enzyme essential for folate metabolism. Thus, patients being treated with MTX should also have supplementation with <strong>folic acid</strong> to prevent folate deficiency. In addition, all patients should be prescribed a topical agent for psoriatic skin lesions. &#160; <br><br>After initiating treatment with MTX, patients should be reassessed in three months&#8217; time to determine response to treatment. If joint inflammation persists after three months, then another DMARD such as <strong>leflunomide&#160;</strong>should be considered. If symptoms persist or worsen, then use of a <strong>biologics agent&#160;</strong>(ie tumor necrosis factor, interleukin inhibitor) should be considered. &#160; <br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/-lzP33hBTyezzhIlEZO81-MxRT_8iDC6/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Methotrexate:</strong><br><span style='opacity:0.9'><strong>Correct:</strong> See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Topical vitamin D analog:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Topical agents, such as a vitamin D analog, are used to manage psoriatic skin plaques, however, they have no effect on joint disease.</span></div><div style='margin-bottom: 12px;'><strong>❌ Topical calcineurin inhibitor:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Topical agents, such as a calcineurin inhibitor, are used to manage psoriatic skin plaques, however, they have no effect on joint disease</span></div><div style='margin-bottom: 12px;'><strong>❌ Secukinumab:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Secukinumab is an interleukin 17 inhibitor that can be used to treat severe PsA that has not been responsive to tumor necrosis factor inhibitors.</span></div><div style='margin-bottom: 12px;'><strong>❌ Etanercept:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>In patients with severe psoriatic arthritis, tumor necrosis factor inhibitors (TNF-inhibitors) such as etanercept or infliximab should be used. However, based on this patient&#8217;s presentation and findings, he likely has moderate disease activity, and should first be started on an oral disease-modifying drug like methotrexate.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 28-year-old woman presents to the clinic with a three-month history of joint pain, fatigue, and a facial rash that appears to worsen with sun exposure. Over the last two weeks, she developed swelling in her ankles and frothy urine. Her past medical history is unremarkable. Temperature is 37.1&#176;C (98.8&#176;F), heart rate is 78/min, blood pressure is 148/93 mmHg, respiratory rate is 16/min, and oxygen saturation is 99% on room air. Physical examination reveals malar erythema on the cheeks and nose sparing the nasolabial folds, pain and swelling of multiple joints of the hands, and bilateral pitting edema up to the mid-shins. Urinalysis shows 3+ proteinuria and microscopic hematuria. Which of the following tests should be performed to confirm the diagnosis? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Renal biopsy"
        },
        {
          "id": 2,
          "text": "ANA titers"
        },
        {
          "id": 3,
          "text": "Serum complement levels (C3 and C4) &#160;"
        },
        {
          "id": 4,
          "text": "Skin biopsy of the facial rash"
        },
        {
          "id": 5,
          "text": "24-hour urinary protein collection"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/l5cLg_FvS9q4fOG3kYMbBkXLROyPKJMI/_.png\"></div><br>This patient's presentation is highly suggestive of<strong>&#160;systemic lupus erythematosus</strong> (SLE) with classical symptoms, including joint pain, fatigue, and a malar rash exacerbated by sun exposure. Additionally, the presence of hypertension, bilateral lower limb edema, proteinuria, and hematuria are highly suggestive of <strong>lupus nephritis</strong>; which can be a complication of SLE. A <strong>renal biopsy</strong> is required to confirm the diagnosis.<br><br>The diagnosis of SLE is often based on a combination of clinical criteria and laboratory findings. Key laboratory tests include <strong>antinuclear antibody (ANA) titers</strong>, which are highly sensitive for SLE but not specific, and <strong>anti-double-stranded DNA (anti-dsDNA) and anti-Smith (anti-Sm) antibodies</strong>, which are more specific for SLE. Classification criteria for SLE were designed to select patients to enroll in research trials. However, since no single finding or test can diagnose lupus, these criteria can be helpful when evaluating patients with suspected SLE.<br><br>When symptoms suggest <strong>kidney involvement</strong> and findings of proteinuria and hematuria are present, <strong>renal biopsy</strong> is necessary to diagnose and classify the type of lupus nephritis. The biopsy can confirm lupus nephritis by demonstrating typical immunofluorescence and histopathological features of <strong>immune complex-mediated glomerulonephritis</strong>. Renal biopsy also provides <strong>prognostic&#160;</strong>information and helps classify the type of nephritis, which ranges from minimal involvement (class I) to advanced sclerosing nephritis (class VI). The results are used to <strong>guide specific treatment strategies</strong>. <br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/wLxJH5NoS-6vmvKagnrE5lIYQzCRprK4/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Renal biopsy:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ ANA titers:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This patient is suspected of having systemic lupus erythematosus (SLE) complicated by lupus nephritis. While ANA titers should be checked as part of the initial evaluation of suspected SLE, they are not specific; and renal biopsy would be needed to confirm lupus nephritis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Serum complement levels (C3 and C4) &#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This patient is suspected of having systemic lupus erythematosus (SLE) complicated by lupus nephritis. Complement levels should be checked as part of the initial evaluation of suspected SLE. Low complement levels can support the diagnosis of SLE, but they are not specific for lupus nephritis; and renal biopsy would be needed to confirm lupus nephritis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Skin biopsy of the facial rash:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This patient is suspected of having systemic lupus erythematosus complicated by lupus nephritis. A skin biopsy can confirm cutaneous lupus, but a kidney biopsy is needed to confirm lupus nephritis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ 24-hour urinary protein collection:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This patient is suspected of having systemic lupus erythematosus complicated by lupus nephritis. While this test should be part of the evaluation to assess the severity of protein loss in nephrotic and nephritic syndromes, it is not diagnostic for lupus nephritis. A renal biopsy is required for a definitive diagnosis when lupus nephritis is suspected. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 24-year-old woman with a history of systemic lupus erythematosus (SLE) presents to the clinic with fatigue, joint pain, and a malar rash that has worsened over the past two weeks. She was diagnosed with SLE two years ago and takes hydroxychloroquine regularly. She has no shortness of breath or lower extremity swelling. Temperature is 37.2&#176;C (99.0&#176;F), heart rate is 88/min, blood pressure is 130/80 mmHg, respiratory rate is 16/min, and oxygen saturation is 98% on room air. Physical examination is significant for a pronounced malar rash and bilateral joint swelling and tenderness in her wrists, hands, knees, and elbows. Laboratory tests are shown below. Which of the following is the best next step in management? &#160;<br><br><table><tbody><tr><td><strong>Laboratory test</strong> &#160; <br></td><td><strong>Results</strong><br></td></tr><tr><td>Hemoglobin<br></td><td>10.2 g/dL<br></td></tr><tr><td>Hematocrit<br></td><td>28%<br></td></tr><tr><td>White blood cell count <br></td><td>5,100 cells/microL<br></td></tr><tr><td>Platelet count<br></td><td>35,000/microL<br></td></tr><tr><td>Reticulocyte count<br></td><td>9%<br></td></tr><tr><td>Mean corpuscular volume<br></td><td>88 fL<br></td></tr><tr><td>Creatinine<br></td><td>0.9 mg/dL<br></td></tr><tr><td><strong>Urinalysis</strong><br></td><td><br></td></tr><tr><td>Specific gravity<br></td><td>1.010<br></td></tr><tr><td>pH<br></td><td>6.0<br></td></tr><tr><td>Protein<br></td><td>Negative<br></td></tr><tr><td>Blood<br></td><td>Negative<br></td></tr><tr><td>Casts</td><td>None<br></td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br>",
      "choices": [
        {
          "id": 1,
          "text": "Oral glucocorticoids"
        },
        {
          "id": 2,
          "text": "Increased dose of hydroxychloroquine"
        },
        {
          "id": 3,
          "text": "Cyclophosphamide"
        },
        {
          "id": 4,
          "text": "Belimumab"
        },
        {
          "id": 5,
          "text": "Angiotensin receptor blocker"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/69YTj0pfRwmA-tWSNDJPFSXgTiWX6T_8/_.png\"></div><br>This patient with a history of <strong>systemic lupus erythematosus (SLE)</strong> presents with increased fatigue, extensive joint inflammation, a worsening malar rash, anemia, and moderate thrombocytopenia; indicating <strong>moderate disease severity</strong>. In addition to hydroxychloroquine, <strong>oral glucocorticoids</strong> (like <strong>prednisone</strong>) would be the preferred treatment for moderate disease activity without major organ-threatening disease. The potent anti-inflammatory and immunosuppressive effects of glucocorticoids can significantly reduce the symptoms of a lupus flare and prevent further progression of the disease.<br><br>Treatment for SLE depends on <strong>disease severity</strong>. All patients with SLE should be started on <strong>hydroxychloroquine </strong>due to its ability to <strong>reduce the frequency of flares</strong> and <strong>prevent long-term organ damage</strong>. For <strong>mild SLE flares</strong>, characterized by symptoms such as mild skin and joint involvement and mild cytopenias, <strong>hydroxychloroquine </strong>should be used and <strong>NSAIDs or low-dose glucocorticoids may be added</strong>. For <strong>moderate disease flares</strong>, which may present with more pronounced symptoms and <strong>moderate cytopenias</strong>, as seen in this patient, treatment includes the <strong>addition of oral moderate-dose glucocorticoids</strong>. If response is inadequate despite combined therapy, additional immunosuppressants (e.g. azathioprine, mycophenolate mofetil) are indicated. For <strong>severe SLE</strong> with organ-threatening complications a more intensive treatment strategy is indicated. This consists of a combination of <strong>hydroxychloroquine, high-dose glucocorticoids, and immunosuppressive therapy</strong> (e.g. mycophenolate mofetil, cyclophosphamide). ACE inhibitors or angiotensin receptor blockers (ARBs) are also used to treat renal disease. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Oral glucocorticoids:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Increased dose of hydroxychloroquine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: While hydroxychloroquine is beneficial for long-term management of systemic lupus erythematosus, it does not provide immediate control of moderate disease flares. This patient's worsening symptoms, especially the moderate hematologic abnormalities (i.e. thrombocytopenia), require the addition of a more potent, rapid-acting treatment like glucocorticoids. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Cyclophosphamide:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Cyclophosphamide is indicated in severe, organ threatening and life-threatening cases of systemic lupus erythematosus (e.g. lupus nephritis). In a moderate flare without evidence of severe organ damage, as seen in this patient, the risks and side effects of cyclophosphamide outweigh its benefits. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Belimumab:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Belimumab is an add-on therapy for patients with active systemic lupus erythematosus. It is not initially indicated to treat moderate disease flares. It is typically used when standard therapies fail to control symptoms. This patient's flare, while moderate, can be managed effectively with standard treatment, such as medium dose glucocorticoids. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Angiotensin receptor blocker:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Angiotensin II receptor blockers are used to treat hypertension and renal disease in patients with systemic lupus erythematosus. This patient does not have evidence of lupus nephritis or hypertension. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    }
  ]
}